ELECTROLYTE Supplement Tablets (calcium 5.2 mg, Potassium 20.8 mg, Magnesium 6 mg ) 2-count packets, Dist. by Honeywell Safety Products USA, Smithfield, RI 02917

cGMP deviations

Recall #: D-0515-2022
Affected scope: 1,474,050 packets
Initiated: January 24, 2022

Compiled from official public sources by the publisher. · Updated September 2026

Ultra Seal Corporation recalled ELECTROLYTE Supplement Tablets (calcium 5.2 mg, Potassium 20.8 mg, Magnesium 6 mg ) 2-cou… - a moderate-severity action.

ELECTROLYTE Supplement Tablets (calcium 5.2 mg, Potassium 20.8 mg, Magnesium 6 mg ) 2-cou… was recalled by Ultra Seal Corporation in February 9, 2022. Reason: cGMP deviations. Check the official notice for the remedy. Verify recall #D-0515-2022 with the FDA Drug before acting.

The recall

Ultra Seal Corporation issued this moderate-severity FDA Drug recall-cGMP deviations.

Moderate
severity level: Class II
classification: February 9, 2022
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0515-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

ELECTROLYTE Supplement Tablets (calcium 5.2 mg, Potassium 20.8 mg, Magnesium 6 mg ) 2-count packets, Dist. by Honeywell Safety Products USA, Smithfield, RI 02917

Reason for recall

cGMP deviations

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-0515-2022
Date reported	February 9, 2022
Date initiated	January 24, 2022
Recalling firm	Ultra Seal Corporation
Firm location	New Paltz, NY
Affected scope	1,474,050 packets
Distribution	Nationwide within the United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0515-2022) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

ELECTROLYTE Supplement Tablets (calcium 5.2 mg, Potassium 20.8 mg, Magnesium 6 mg ) 2-count packets, Dist. by Honeywell Safety Products USA, Smithfield, RI 02917. Recalled by Ultra Seal Corporation. Units affected: 1,474,050 packets.

Why was this product recalled? ▼

cGMP deviations

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on February 9, 2022. Severity: Moderate. Recall number: D-0515-2022.

Where was the recalled product distributed? ▼

Distribution: Nationwide within the United States.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Children's Nightgowns Recalled by AllMeIn… 2022-02-09 Petzl Recalls Lanyards with Carabiners Du… 2022-02-09 Stack Em' Up Books Recalls Children's Sta… 2022-02-09 Stance Recalls Kids Crew Socks Due to Cho… 2022-02-09

Similar Dietary Supplements · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Simply Good Proteins Collagen Protein Hyd… 2022-02-16 Medium Chain Triglyceride (MCT) Powder 50… 2022-02-02 Nutricrafters MCT - Instant coconut milk … 2022-02-02 Boba Origin Brown-Sugar Milk Tea 100% WHE… 2022-01-19

Compare this recall with Goody King Magnetic Building Cubes and Blocks Recalled Due … → · All Dietary Supplements recalls

This recall: FDA Drug, reported February 9, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026